FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rotigotine 4mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 20micrograms/24hours patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nuvelle TS Phase II patches (Schering Health Care Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour patches 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour patches 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour patches 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 7micrograms/24hours patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 7micrograms/24hours patches 12 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (Merck Pharmaceuticals) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norelgestromin 150micrograms/24hours / Ethinylestradiol 20micrograms/24hours patches 9 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Gedeon Richter (UK) Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 10micrograms/24hours patches 2 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 10micrograms/24hours patches 6 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 200micrograms/24hours patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 200micrograms/24hours patches 12 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 2 patches (Boehringer Ingelheim Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Oxybutynin 3.9mg/24hours patches 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Kentera 3.9mg/24hours patches (Accord Healthcare Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Diclofenac 1% patches 10 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voltarol Gel Patch 1% medicated plasters (Novartis Consumer Health UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5micrograms/hour patches 2 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 10micrograms/hour patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 20micrograms/hour patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 20micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour patches 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Janssen-Cilag Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches 28 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nuvelle TS Phase II patches (Schering Health Care Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (Merck Pharmaceuticals) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (Merck Pharmaceuticals) 12 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Gedeon Richter (UK) Ltd) 9 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 2 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Theramex HQ UK Ltd) 6 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 2 patches (Boehringer Ingelheim Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 2 patches (Boehringer Ingelheim Ltd) 12 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Kentera 3.9mg/24hours patches (Accord Healthcare Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voltarol Gel Patch 1% medicated plasters (Novartis Consumer Health UK Ltd) 10 patch 5 x 2 patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 2 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 20micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Janssen-Cilag Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) 28 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmach 25micrograms/hour transdermal patches (Ratiopharm UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmach 50micrograms/hour transdermal patches (Ratiopharm UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmach 75micrograms/hour transdermal patches (Ratiopharm UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmach 100micrograms/hour transdermal patches (Ratiopharm UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmach 25micrograms/hour transdermal patches (Ratiopharm UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmach 75micrograms/hour transdermal patches (Ratiopharm UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmach 100micrograms/hour transdermal patches (Ratiopharm UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmach 50micrograms/hour transdermal patches (Ratiopharm UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Waymade Healthcare Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm TTS 1.5mg patches (Waymade Healthcare Plc) 2 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 100 patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 37.5micrograms/24hours patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 100 patches (Doncaster Pharmaceuticals Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 37.5micrograms/24hours patches (Doncaster Pharmaceuticals Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Doncaster Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradot 75micrograms/24hours patches (Doncaster Pharmaceuticals Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 50 patches (Doncaster Pharmaceuticals Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 25 patches (Doncaster Pharmaceuticals Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 100 patches (Doncaster Pharmaceuticals Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm MX 50 patches (Doncaster Pharmaceuticals Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estraderm TTS 25 patches (Doncaster Pharmaceuticals Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estragest TTS patches (Doncaster Pharmaceuticals Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 5 of 21 Next End

This concept is not in any reference sets

Back to Start